AIL
MRTX

AGF Investments LLC’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

AGF Investments LLC’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.54M Buy
+22,075
New +$1.63M 0.14% 108
2022
Q1 		– Sell
-5,885
Closed -$863K – 530
2021
Q4 		$863K Buy
+5,885
New +$914K 0.07% 105

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AGF Investments LLC's MRTX Position: Q3 2022 in Review

AGF Investments LLC opened a new position in Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2022: 22,075 shares worth $1.54M. The stake represents 0.14% of the portfolio and ranks #108 among its holdings. This is a return to the name: AGF Investments LLC previously reported a position in MRTX as recently as Q4 2021.

AGF Investments LLC first reported a position in MRTX in Q4 2021 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold MRTX as of Q3 2022.

  • AGF Investments LLC held 22,075 shares of Mirati Therapeutics, Inc. Common Stock worth $1.54M as of Q3 2022.
  • Mirati Therapeutics, Inc. Common Stock was a new AGF Investments LLC position in Q3 2022.
  • Mirati Therapeutics, Inc. Common Stock made up 0.14% of AGF Investments LLC's portfolio in Q3 2022, its #108 holding.
  • AGF Investments LLC first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2021 and has held it in 2 quarters since.
  • 243 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.